NM_005539.5:c.662G>A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_005539.5(INPP5A):c.662G>A(p.Arg221Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000692 in 1,603,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005539.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000805 AC: 20AN: 248506 AF XY: 0.0000670 show subpopulations
GnomAD4 exome AF: 0.0000352 AC: 51AN: 1450918Hom.: 0 Cov.: 29 AF XY: 0.0000292 AC XY: 21AN XY: 720086 show subpopulations
GnomAD4 genome AF: 0.000394 AC: 60AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74470 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.662G>A (p.R221Q) alteration is located in exon 9 (coding exon 9) of the INPP5A gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at